The TGA medicinal cannabis landscape has evolved since its legalisation in 2016, and it continues to evolve. And many organisation are being caught for non-compliance with TGA standards including advertising.
With experience across prescription cannabis medicines, consumer cannabis medicines and and TGO93, the Enimera RegsPlus team can drive and support your organisation’s medicinal cannabis projects.
Whether your organisation seeks regulatory resource for a medicinal cannabis product strategy or application, or ad-hoc TGO93-related or SAS/Authorised Prescriber advice, contact Enimera RegsPlus to understand how we can support you.
For more on medicinal cannabis regulation and TGA GMP requirements, click here.